CJC-1295 (No-DAC) + Ipamorelin CJC-1295 (No-DAC) + Ipamorelin is a dual peptide combination studied for its synergistic stimulation of growth hormone (GH) release and downstream IGF-1 production
Numerous other trials have demonstrated positive cardiovascular outcomes with focus on HFpEF in the SUMMIT trial for tirzepatide and the STEP-HFpEF trial for semaglutide [50,51,52]
, , , , , .
Skin Rejuvenation and Anti-Aging Protocol Dose: 1 to 2 mg per day Route: Subcutaneous (abdomen, thigh, or upper arm) Frequency: Daily, 5 days on, 2 days off Cycle: 8 to 12 weeks on, 4 weeks off Expected results: 4 to 8 weeks for visible improvement Best for: Fine lines, skin elasticity, skin density, overall skin quality In a 12-week facial cream study (human trial, 71 women), 70% showed increased collagen production with GHK-Cu, compared to 50% with vitamin C and 40% with retinoic acid (Pickart et al., 2015)